JUL 30, 2021 7:27 AM PDT

Obesity Reduces Mortality in Advanced Prostate Cancer

WRITTEN BY: Annie Lennon

Obese patients with an advanced form of prostate cancer survive longer than their slimmer counterparts, according to researchers at San Raffaele University in Italy. The study was presented at the 36th Annual European Association of Urology (EAU) Congress

Obesity is generally known as a risk factor for many conditions, including several kinds of cancer. However, some studies have shown that obesity offers a survival advantage in some cancers, in what is known as the 'obesity paradox'. 

For the present study, the researchers recruited 1577 patients with metastatic castration-resistant prostate cancer (mCRPC) for three phase 3 randomized controlled trials. Their average age was 69 years, and their median body mass index (BMI) was 28. The median follow-up for participants was 12 months. 

In the end, the researchers found that 30% of obese patients (BMI >30) survived the 36-month follow-up. The same was true for just 20% of those who were overweight (25<BMI<30) and of normal weight (20< BMI <25). 

The researchers say that this is another example of the obesity paradox. Its underlying mechanisms, however, are unknown. One suggestion, they say, is that as older obese patients tend to take medications for other conditions, their enhanced survival rate may be due to some unknown interactions. 

Meanwhile, Peter Albers, Peter Albers who chairs the EAU Scientific Congress, suggested that patients with a higher BMI may tolerate treatment toxicity and side effects better than those with lower BMI's. He added that hormones found in tissue fat may have a protective effect and that healthy men with slightly higher BMI's are known to have a higher overall life expectancy compared to those who are very slim. 

Until further research is conducted, however, these explanations remain hypotheses. Therefore, the researchers do not recommend weight gain for people with this disease. 

 

Sources: 36th Annual European Association of Urology CongressEurekAlert

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
MAY 14, 2021
Cancer
Obesity-related cancer deaths are declining too slowly
MAY 14, 2021
Obesity-related cancer deaths are declining too slowly
A study published this week in JAMA Network Open shows that although obesity-related cancer deaths are falling, they are ...
JUN 27, 2021
Cancer
Are e-cigarettes actually helpful for smoking cessation?
JUN 27, 2021
Are e-cigarettes actually helpful for smoking cessation?
New research published in The Lancet Public Health reports on a study that looked at interventions targeting e-cigarette ...
JUL 08, 2021
Genetics & Genomics
Is It Possible to Prevent Leukemia in Down Syndrome Patients?
JUL 08, 2021
Is It Possible to Prevent Leukemia in Down Syndrome Patients?
Children with Down syndrome have a significantly higher likelihood myeloid leukemia occurring in the first five years of ...
JUL 18, 2021
Cancer
Light Alcohol Use Linked to Higher Cancer Risk
JUL 18, 2021
Light Alcohol Use Linked to Higher Cancer Risk
Moderate alcohol use is linked to a substantially higher risk of several forms of cancer, including breast, colon, and o ...
AUG 07, 2021
Cancer
New Drug Combo Eliminates Pancreatic Cancer in Mice
AUG 07, 2021
New Drug Combo Eliminates Pancreatic Cancer in Mice
A combination of three immunotherapy drugs can eliminate pancreatic tumors in mice. The study was published in Canc ...
AUG 29, 2021
Cancer
Researchers Bioprint Deadly Brain Tumor with 3D Printer
AUG 29, 2021
Researchers Bioprint Deadly Brain Tumor with 3D Printer
Researchers have managed to print an entire active and viable glioblastoma tumor- the deadliest form of brain cancer- us ...
Loading Comments...